STOCK TITAN

Obagi Cosmeceuticals Announces the Launch of Daily Hydro-Drops® Rejuvenating Eye Gel Cream

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Obagi, a leader in skincare innovation, under Waldencast plc, launches Daily Hydro-Drops® Rejuvenating Eye Gel Cream to target delicate eye skin. The product promises hydration, brightness, and reduced puffiness. Formulated with clinically proven ingredients, it aims to address key skin concerns around the eyes.
Positive
  • None.
Negative
  • None.

The introduction of Obagi's Daily Hydro-Drops® Rejuvenating Eye Gel Cream represents a strategic expansion of an already successful product line. This move is likely to capitalize on the established reputation of the Daily Hydro-Drops® collection, potentially increasing customer loyalty and attracting new consumers. The specific focus on a challenging area of skincare—the eye region—addresses a common consumer concern, which could lead to increased market share in the eye care sub-segment.

From a market perspective, the use of clinically proven ingredients and technology such as Isoplentix® suggests a competitive edge. However, the premium pricing at $75 could limit market penetration to higher-income demographics, potentially affecting sales volume. The launch through physician channels before general availability may stimulate initial interest among health-conscious consumers, but it remains to be seen how this strategy will impact long-term sales through direct-to-consumer channels.

The release of a new premium skincare product has implications for Waldencast plc's revenue streams, particularly if the product gains traction in the market. The immediate financial impact will depend on the product's acceptance and the effectiveness of the marketing strategy. As Obagi is a subsidiary of Waldencast, success in this launch could reflect positively on Waldencast's stock performance, especially if sales projections are met or exceeded.

Investors should monitor consumer reception and sales data post-release, especially given the product's premium price point. The financial performance of this product line could serve as an indicator of the company's ability to innovate and maintain its position in the competitive skincare market. It will be important to analyze quarterly financial reports following the product launch for indications of its contribution to Waldencast's overall revenue.

The Rejuvenating Eye Gel Cream's formulation with lipids, emollients and antioxidants targets the delicate eye area, which is prone to dryness and signs of aging. The inclusion of Niacinamide and natural oils may enhance the skin's barrier function, while the oat derivative and Tuberose aim to smooth and reduce puffiness, respectively. The clinical testing results and the hypoallergenic, non-comedogenic properties are reassuring, indicating the product's safety and potential efficacy.

However, consumer results may vary and long-term benefits are yet to be established. The dual-sided metal applicator's cooling effect is a novel feature that can enhance user experience but does not necessarily contribute to the product's efficacy. It's crucial for consumers to have realistic expectations and understand that skincare results are often cumulative and require consistent use over time.

This New Product is the Latest Introduction to Obagi’s Daily Hydro-Drops® Collection

LONG BEACH, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Obagi Cosmeceuticals LLC (“Obagi”), a leader in skincare innovation and the originator of medical-grade skincare and a subsidiary of Waldencast plc, (NASDAQ: WALD) (“Waldencast”), today announced the launch of Daily Hydro-Drops® Rejuvenating Eye Gel Cream. As the latest addition to the bestselling Daily Hydro-Drops® portfolio, known for the brand’s beloved “liquid gold” Facial Serum, the Rejuvenating Eye Gel Cream is meticulously formulated with clinically proven moisturizers, oils, brighteners, and antioxidants to precisely target the delicate skin around the eyes.

Daily Hydro-Drops® Rejuvenating Eye Gel Cream and Daily Hydro-Drops® Facial Serum

While dry skin can appear anywhere, treating around the eye is one of the most challenging areas because it’s the thinnest area of skin on the body, with fewer oil glands than other areas of the face to keep it moisturized and protected. Daily Hydro-Drops® Rejuvenating Eye Gel Cream offers a transformative solution to the eye area, bringing an immediate boost in radiance, while simultaneously rejuvenating the eye area with 24-hour lasting hydration for a more awakened appearance. The product offers a thoroughly researched and developed solution to address key skin concerns such as dry and tight skin, dark circles and puffiness around the eyes.

“We had a white space in our portfolio for a brightening and hydrating eye product and we are excited to grow our bestselling Daily Hydro-Drops® collection with this new eye cream,” said the CMO of Obagi, Justin Giouzepis. “As the authority on medical-grade skincare, it was critical for us to create a product that provides transformational results. With just one swipe, Rejuvenating Eye Gel Cream delivers brighter, smoother, and more hydrated skin around the eyes. Plus, we added a cooling, dual-sided metal applicator to help massage the cream into skin making it so easy and convenient to use.”

Ophthalmologist and dermatologist-tested, hypoallergenic, and non-comedogenic, Daily Hydro-Drops® Rejuvenating Eye Cream is formulated with a rich combination of lipids and emollients, skin-tightening sugars, and antioxidants to refresh and quench the fragile skin around the area. Featuring Obagi’s Isoplentix® technology, key ingredients remain suspended and preserved in the formula, only releasing their benefits upon application. With Niacinamide, Meadowfoam Seed, Abyssinian and Hibiscus Oils to help soften the appearance of fine lines and wrinkles, as well as an oat Derivative for smoothing effects and Tuberose to reduce unwanted puffiness, the skin around the eyes is rejuvenated. Complementing the formula is the contoured metal applicator, which provides an instant cooling and soothing effect for a more refreshed feeling and appearance.

Multimodal efficacy testing was completed to demonstrate the efficacy of Daily Hydro-Drops® Rejuvenating Eye Gel Cream, revealing the below findings after various time increments:

  • Immediately after application:
    • 100% of participants had an immediate improvement in hydration*
    • 94% of participants agreed the product provides a quick moisture fix to the delicate eye area^
  • 3 Days after using:
    • Majority of participants agreed eye bags are less prominent/noticeable^
  • 1 Week of use:
    • 89% of participants agreed the thin skin under eyes feels less tight and dry^
    • Majority of participants agreed the under-eye area looks less crepey and saggy^

Daily Hydro-Drops® Rejuvenating Eye Gel Cream is now available for $75 through partnering physician channels, and will be available for customers to purchase on Obagi.com on March 21st.

*Results based on a 2023 bio-instrumentation study. Data on file at Obagi Cosmeceuticals LLC.
^Results based on a 2023 product usage test. Data on file at Obagi Cosmeceuticals LLC.

About Obagi Cosmeceuticals
Obagi Cosmeceuticals is an industry-leading, advanced skincare line rooted in research and skin biology, refined with a legacy of 30 years’ experience. First known as leaders in the treatment of hyperpigmentation with the Obagi Nu-Derm® System, Obagi products are designed to diminish the appearance of premature aging, photodamage, skin discoloration, acne, and sun damage. Backed by science and trusted by professionals, Obagi empowers individuals to achieve healthy, beautiful skin.
More information about Obagi is available on the brand’s website, https://www.obagi.com.

About Waldencast
Founded by Michel Brousset and Hind Sebti, Waldencast’s ambition is to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling conscious, high-growth purpose-driven brands. Waldencast’s vision is fundamentally underpinned by its brand-led business model that ensures proximity to its customers, business agility, and market responsiveness, while maintaining each brand’s distinct DNA. The first step in realizing its vision was the business combination with Obagi Cosmeceuticals and Milk Makeup. As part of the Waldencast platform, its brands will benefit from the operational scale of a multi-brand platform; the expertise in managing global beauty brands at scale; a balanced portfolio to mitigate category fluctuations; asset-light efficiency; and the market responsiveness and speed of entrepreneurial indie brands. For more information please visit: https://ir.waldencast.com/.

Media Contact:
obagi@icrinc.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e7c231d6-54b0-476b-b6fb-94b7fc795868

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3d974942-2b43-4b92-9a3e-7141ab8e918d


FAQ

What is the latest product launched by Obagi under Waldencast plc?

The latest product launched by Obagi under Waldencast plc is the Daily Hydro-Drops® Rejuvenating Eye Gel Cream.

What are the key benefits of the Rejuvenating Eye Gel Cream according to the PR?

The Rejuvenating Eye Gel Cream promises hydration, brightness, reduced puffiness, smoother skin, and improved appearance of fine lines and wrinkles.

What ingredients are included in the Daily Hydro-Drops® Rejuvenating Eye Gel Cream?

The Daily Hydro-Drops® Rejuvenating Eye Gel Cream includes Niacinamide, Meadowfoam Seed, Abyssinian and Hibiscus Oils, oat Derivative, and Tuberose to rejuvenate the skin around the eyes.

How much does the Daily Hydro-Drops® Rejuvenating Eye Gel Cream cost?

The Daily Hydro-Drops® Rejuvenating Eye Gel Cream is available for $75 through partnering physician channels.

When will the Daily Hydro-Drops® Rejuvenating Eye Gel Cream be available for purchase on Obagi.com?

The Daily Hydro-Drops® Rejuvenating Eye Gel Cream will be available for customers to purchase on Obagi.com on March 21st.

Waldencast plc

NASDAQ:WALD

WALD Rankings

WALD Latest News

WALD Stock Data

515.64M
11.26M
56.65%
37.91%
0.57%
All Other Miscellaneous Chemical Product and Preparation Manufacturing
Manufacturing
Link
United States of America
WHITE PLAINS